Wegovy Insurance Requirements In 2026: What Plans Usually Demand And How To Get Approved Faster

If you've tried to get Wegovy covered, you already know the hardest part often isn't the prescription, it's the paperwork. In 2026, most insurers still treat Wegovy as a "high-scrutiny" medication, which means they'll usually require prior authorization, specific BMI thresholds, and clear documentation of medical necessity.

The good news: you can often speed things up (and avoid preventable denials) by understanding what plans typically ask for and making sure your clinician submits the exact details insurers look for.

What Insurance Typically Requires For Wegovy Coverage (The Usual Checklist)

Insurance criteria vary by plan, but "Wegovy insurance requirements" tend to cluster around a predictable checklist. If you prepare these items up front, you reduce the odds of a quick denial for "insufficient documentation."

Here's what many plans usually want to see.

1. BMI documentation (and sometimes a higher threshold)

Most plans look for a documented body mass index (BMI) of at least 30. Some stricter policies require a higher BMI (for example, 40). What matters is what's in your insurer's written criteria, not what a friend's plan required.

Practical tip: make sure your recorded height and weight are current and measured in clinic (not self-reported). A tiny documentation mismatch can cause a denial.

2. The covered indication matters more than you'd think

Coverage often depends on why you're using Wegovy.

For Medicare Part D in particular, coverage is tied to FDA-approved indications such as cardiovascular risk reduction. It is generally not covered for weight loss alone. Commercial and Medicaid plans may cover Wegovy for certain indications more readily, but weight-management-only coverage can still be limited.

Translation: your chart has to match the plan's covered use case, and your clinician has to code it accurately.

3. Clinical documentation of medical necessity

Insurers typically want a clear story in your medical record, not just a number on the scale. Common documentation elements include:

• Diagnosis codes related to obesity and/or cardiometabolic risk
• Relevant labs (for example, lipids, A1c when appropriate)
• Blood pressure readings and comorbidity history
• Clinical notes that explain prior efforts and why Wegovy is medically appropriate

This isn't "extra" paperwork, this is the core evidence the utilization review team uses.

4. Step therapy (try-this-first rules)

Some plans require you to try other therapies first (step therapy). That might mean documented lifestyle intervention attempts, other weight-management medications, or specific program participation, depending on the plan.

If your plan has step therapy, the fastest path is usually documentation that you already completed the steps, or a clinician's rationale for why a step is inappropriate for you.

5. Prior authorization is almost always required

For Wegovy, prior authorization (PA) is the rule, not the exception. Think of PA as the insurer's checkpoint where your clinician must prove you meet the plan's criteria before the pharmacy can dispense it under coverage.

How Prior Authorization Works For Wegovy (And What Paperwork Matters Most)

Prior authorization can feel like a black box, but the mechanics are fairly consistent.

What PA actually is

Your clinician submits a PA request to your insurance plan. A utilization management team then compares what's submitted against the plan's Wegovy coverage policy. If your documentation matches the criteria, the plan approves it and you pay according to your benefits (copay, coinsurance, deductible).

Cost-sharing varies, but many people with coverage end up somewhere around $25 to $150 per month. Your exact out-of-pocket depends on your formulary tier, whether you've met your deductible, and whether the prescription is filled monthly or as a longer supply.

What documentation tends to matter most

Insurers don't just want "patient wants weight loss." They typically want specific, check-the-box details:

• Your current BMI and the date it was measured
• The diagnosis/indication being treated (and that it matches the plan's policy)
• Comorbidities and risk factors documented clearly
• Prior treatment attempts (nutrition plan, activity, behavioral support, other meds when required)
• A short, clinically coherent rationale: why Wegovy now

If one key element is missing, the PA may get denied even if you "should" qualify.

Why electronic prior authorization (ePA) can speed things up

If your clinic uses electronic prior authorization (ePA), it can reduce delays because the request is routed through standardized electronic fields rather than faxed forms. Medicare Part D plans have supported this standard since January 2022, and many commercial plans also use it.

The catch: ePA is only as good as the data entered. If the BMI is wrong, the diagnosis code is missing, or the indication isn't clearly documented, ePA can deliver a faster denial.

How to help your clinician's office help you

You can't (and shouldn't) do the medical documentation yourself, but you can make the process smoother by:

• Asking your insurer or pharmacy benefits manager whether Wegovy is on formulary and whether PA and step therapy apply
• Requesting the plan's written PA criteria so your clinician knows the exact requirements
• Confirming your most recent clinic-measured height/weight are in the chart
• Ensuring your comorbidities are listed in the problem list (many charts are surprisingly outdated)

One small but important mindset shift: PA isn't about convincing someone you "deserve" treatment. It's about matching the insurer's policy language with clear, complete clinical documentation.

If You’re Denied: Your Best Next Steps To Win Coverage Or Lower Costs

A denial is frustrating, but it's not always the end of the road. Many denials are fixable once you know the reason.

Step 1: Get the denial reason and the actual PA criteria in writing

Call your insurer and request:

• The denial letter (with the specific reason code or rationale)
• The plan's written Wegovy prior authorization criteria

This is a big deal. "Not medically necessary" can mean anything from "BMI not documented" to "indication not covered." You need the specific gap.

Step 2: Loop your prescriber in with the exact criteria

Share the criteria with your clinician's office so they can submit a corrected PA or additional clinical justification. Common fixes include:

• Updating BMI documentation (with dates)
• Correcting diagnosis codes
• Adding relevant comorbidity details
• Documenting prior lifestyle or step-therapy requirements

If you're working with a telehealth provider, ask whether they handle appeals routinely and what turnaround time to expect.

Step 3: Appeal strategically (don't just resubmit the same packet)

An appeal works best when it addresses the insurer's stated reason for denial point-by-point. Sometimes it also helps for your clinician's office to contact utilization management to clarify what specific evidence would satisfy the policy.

Step 4: If coverage still isn't available, explore legitimate cost-lowering paths

Depending on your insurance type and eligibility:

• Manufacturer savings programs may reduce copays for people with commercial insurance (these usually do not apply to government plans).
• If you're hearing about new access pathways, ask specifically whether a CMS demonstration program beginning in 2026 applies to you and how enrollment works.

Also check practical plan details that can change your out-of-pocket more than you expect:

• Is the drug on a different tier if filled through mail order?
• Is a 90-day supply allowed (and cheaper per month)?
• Are you hitting a deductible that makes the first fill expensive and later fills cheaper?

A quick word about "workarounds"

If you're tempted to use diagnosis shortcuts or mismatched coding to force coverage, don't. Besides being ethically problematic, it can create problems later, especially if your chart no longer accurately reflects why you're on the medication.

Digestive discomfort is one of the most common reasons people struggle with GLP-1 medications. Targeted nutrition support can make a real difference in tolerability. Casa de Sante's physician-formulated digestive enzymes, synbiotics, and motility support supplements are designed specifically for sensitive stomachs on GLP-1 therapy. See what's available at casadesante.com.

This article is for educational purposes only and is not medical advice. Always consult your healthcare provider before making changes to your treatment plan.

Conclusion

In 2026, Wegovy insurance requirements usually come down to a few predictable checkpoints: documented BMI, a covered indication, clear medical-necessity notes, and prior authorization that matches your plan's exact policy language. If you're denied, don't guess, get the written criteria, identify the missing element, and appeal with targeted documentation. The process is tedious, but with the right paperwork, it often moves faster than you'd expect.

Wegovy Insurance Requirements - Frequently Asked Questions

What are the common insurance requirements for Wegovy coverage?

Most insurance plans require a documented BMI of at least 30, a covered medical indication aligned with FDA approvals, clinical documentation of medical necessity, step therapy completion if applicable, and prior authorization before approving Wegovy.

Why does Wegovy usually need prior authorization from insurance providers?

Prior authorization ensures insurers verify that your medical documentation meets their specific criteria for Wegovy coverage, confirming eligibility and medical necessity before they approve coverage and allow pharmacy dispensing.

How does BMI affect Wegovy insurance approval?

Insurers typically require an in-clinic measured BMI of 30 or higher; some stricter plans require 40+. Accurate, current height and weight documentation is critical to avoid denial based on insufficient BMI evidence.

Does Medicare Part D cover Wegovy for weight loss?

No, Medicare Part D generally covers Wegovy only for FDA-approved indications like cardiovascular risk reduction, not solely for weight loss. Commercial and Medicaid plans offer varied coverage for weight management use.

What should I do if my insurance denies Wegovy coverage?

Request the denial reason and written prior authorization criteria from your insurer, share them with your clinician for additional documentation, appeal strategically addressing denial points, and explore manufacturer savings or CMS programs if needed.

Can electronic prior authorization speed up Wegovy coverage approvals?

Yes, electronic prior authorization (ePA) can reduce delays by routing requests through standardized electronic fields, helping Medicare and commercial plans quickly process your clinician's submission if all data is accurate.